Shine-On BioMedical Co.,Ltd. (TPEX:6926)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
73.90
+0.30 (0.41%)
Sep 19, 2025, 2:55 PM CST

Shine-On BioMedical Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
20.6344.66102.02373.16824.98
Short-Term Investments
9369991,03579381
Cash & Short-Term Investments
956.631,0441,1371,166905.98
Cash Growth
-12.42%-8.21%-2.50%28.72%-
Accounts Receivable
--10--
Other Receivables
1.082.312.061.18-
Receivables
1.082.3112.061.18-
Prepaid Expenses
15.476.344.571.490.32
Other Current Assets
0.05--0-
Total Current Assets
973.231,0521,1541,169906.31
Property, Plant & Equipment
2.112.831.543.033.99
Other Intangible Assets
4.363.623.593.361.24
Long-Term Deferred Tax Assets
--0.042.27-
Other Long-Term Assets
2.391.030.890.280.28
Total Assets
982.081,0601,1601,178911.82
Accounts Payable
--2.86-0.19
Accrued Expenses
1.240.260.570.011
Current Portion of Leases
1.31.240.540.540.97
Other Current Liabilities
5.9239.0919.292.610.59
Total Current Liabilities
8.4640.623.263.172.74
Long-Term Leases
0.681.36-0.981.52
Long-Term Deferred Tax Liabilities
0.010.26---
Total Liabilities
9.1542.2123.264.144.26
Common Stock
498498498498430
Additional Paid-In Capital
703.6703.6703.6703.6486
Retained Earnings
-228.67-184.03-65.14-27.98-8.43
Shareholders' Equity
972.931,0181,1361,174907.57
Total Liabilities & Equity
982.081,0601,1601,178911.82
Total Debt
1.982.60.541.522.48
Net Cash (Debt)
954.651,0411,1361,165903.5
Net Cash Growth
-12.35%-8.40%-2.42%28.90%-
Net Cash Per Share
19.1720.9022.8225.6548.91
Filing Date Shares Outstanding
49.849.849.849.849.8
Total Common Shares Outstanding
49.849.849.849.849.8
Working Capital
964.771,0121,1301,166903.57
Book Value Per Share
19.5420.4322.8223.5718.22
Tangible Book Value
968.571,0141,1331,170906.33
Tangible Book Value Per Share
19.4520.3622.7523.5018.20
Machinery
1.261.231.861.791.31
Leasehold Improvements
0.020.020.370.370.37
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.